CEVR analyzes the benefits, risks, and costs of strategies to improve health and health care.

About Us
Data

News & Events

Recent Publications

What types of real-world evidence studies do U.S. commercial health plans cite in their specialty drug coverage decisions?

Pharmacoepidemiology and Drug Safety

Panzer AD, Margaretos NM, Lai RC, Enright DE, Chambers JD. What types of real-world evidence studies do U.S. commercial health plans cite in their specialty drug coverage decisions? Pharmacoepidemiology and Drug Safety 2020;1–5.

The supercar stays in the garage: Factors preventing indirect comparisons of novel medicines targeting the same condition

Journal of Managed Care & Specialty Pharmacy

Ollendorf DA, Kim E, Bridger N, Naci H. The supercar stays in the garage: Factors preventing indirect comparisons of novel medicines targeting the same condition. Journal of Managed Care & Specialty Pharmacy 2020;26(3):333–4.

Comparing inpatient costs of heart failure admissions for patients with reduced and preserved ejection fraction with or without type 2 diabetes

Cardiovascular Endocrinology & Metabolism

Olchanski N, Amanda VR, Cohen JT, DeNofrio D. Comparing inpatient costs of heart failure admissions for patients with reduced and preserved ejection fraction with or without type 2 diabetes. Cardiovascular Endocrinology & Metabolism 2020;9(1):17–23.

Are low and middle-income countries prioritising high-value healthcare interventions?

BMJ Global Health

Leech AA, Kim DD, Cohen JT, Neumann PJ. Are low and middle-income countries prioritising high-value healthcare interventions? BMJ Global Health 2020;5(2).

Prevention of non-communicable disease: Best buys, wasted buys, and contestable buys

BMJ

Isaranuwatchai W, Teerawattananon Y, Archer RA, Luz A, Sharma M, Rattanavipapong W, Anothaisintawee T, Bacon RL, Bhatia T, Bump J, Chalkidou K, Elshaug AG, Kim DD, Reddiar SK, Nakamura R, Neumann PJ, Shichijo A, Smith PC, Culyer AJ. Prevention of non-communicable disease: Best buys, wasted buys, and contestable buys. BMJ 2020.

Hospital care at home: Better, cheaper, faster?

Annals of Internal Medicine

Wong JB, Cohen JT. "Hospital care at home: Better, cheaper, faster?," Annals of Internal Medicine Editorial, January 21, 2020.

Outcome measures for oncology alternative payment models: Practical considerations and recommendations

The American Journal of Managed Care

Hlávka JP, Lin PJ, Neumann PJ. Outcome measures for oncology alternative payment models: Practical considerations and recommendations. The American Journal of Managed Care 2019.

Does the Institute for Clinical and Economic Review revise its findings in response to industry comments?

Value in Health

Cohen JT, Silver MC, Ollendorf DA, Neumann PJ. Does the Institute for Clinical and Economic Review revise its findings in response to industry comments? Value in Health 2019;22(12):1396–401.

Cost-effectiveness analysis in pediatric imaging: The evidence (or lack thereof) thus far

Journal of the American College of Radiology

Otero HJ, Degnan AJ, Kadom N, Neumann PJ, Lavelle TA. Cost-effectiveness analysis in pediatric imaging: The evidence (or lack thereof) thus far. Journal of the American College of Radiology 2019.

Little consistency in evidence cited by commercial plans for specialty drug coverage

Health Affairs

Chambers JD, Panzer AD, Pope EF, Graff JS, Neumann PJ. Little consistency in evidence cited by commercial plans for specialty drug coverage. Health Affairs 2019;38(11):1882–6.

Comparative modeling to inform health policy decisions: A step forward

Annals of Internal Medicine Editorial

Kim DD, Neumann PJ. "Comparative modeling to inform health policy decisions: A step forward," Annals of Internal Medicine Editorial," November 4, 2019.

Influence of modeling choices on value of information analysis: An empirical analysis from a real-world experiment

PharmacoEconomics

Kim DD, Guzauskas GF, Bennette CS, Basu A, Veenstra DL, Ramsey SD, Carlson JJ. "Influence of modeling choices on value of information analysis: An empirical analysis from a real-world experiment," PharmacoEconomics 2019;:1–9.

Variation in US private health plans’ coverage of orphan drugs

The American Journal of Managed Care

Chambers JD, Panzer AD, Kim DD, Margaretos NM, Neumann PJ. Variation in US private health plans’ coverage of orphan drugs. The American Journal of Managed Care. 2019;25(10):508-512.

Cost-effectiveness of nutrition policies to discourage processed meat consumption: Implications for cancer burden in the United States

American Journal of Preventive Medicine

Kim DD, Wilde PE, Michaud DS, Liu J, Lizewski L, Onopa J, Mozaffarian D, Zhang FF, Wong JB. Cost Effectiveness of Nutrition Policies on Processed Meat: Implications for Cancer Burden in the U.S. American Journal of Preventive Medicine 2019;57(5).

The CEVR Team

Our team of experienced, dedicated researchers is led by health economists Peter Neumann and Josh Cohen. Together we produce cutting-edge health care cost-effectiveness research.

Meet the CEVR Team

Our Databases

Our comprehensive databases provide the information individuals and organizations need to analyze the benefits, risks, and costs of strategies to improve health and health care.